dpp4 vs sglt2 vs glp-1 SGLT-2 inhibitors, receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study GLP-1-RA and DPP-4 inhibitors in

When taking GLP-1 medications, its advisable to steer clear of high-fat foods, sugary treats, and large meals

Weekly injectable medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) require a single injection once per week, making the choice of day particularly important as it establishes a pattern you will follow for the duration of your treatment

"When we are talking about the GLP-1 receptor agonist, the receptors that the medication works on is in the brain as much as it is in the gut

Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis

Available from: J L Sievenpiper 1 2 3 , J Ard 4 , M Blher 5 , W Chen 6 , J B Dixon 7 , A Fitch 8 , L Gigliotti 9 , K Khunti 10 , A Lecube 11 12 , M E J Lean 13 , B Mittendorfer 14 , A F H Pfeiffer 15 , D H Ryan 16 , T Vilsbll 17 18 , L F Van Gaal 19

Relationships between gastric emptying, intragastric meal distribution and blood glucose concentrations in diabetes mellitus